tyrosine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

tyrosine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adhikari, A; Adhikari, S; Allen, JR; Alpert, EJ; Do, D; Gallagher, K; Garcia, SP; Heckman, CA; Heinäniemi, M; Hyvärinen, N; Iyer, S; Jin, AH; Kelliher, M; Langenau, DM; Laukkanen, S; Lohi, O; Loontiens, S; McCarthy, K; Moisio, S; Oksa, L; Pello, A; Ruokoranta, T; Veloso, A; Whelton, L; Yan, C; Yang, Q; Yoder, JA1

Other Studies

1 other study(ies) available for tyrosine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
    Blood, 2022, 10-27, Volume: 140, Issue:17

    Topics: Animals; Cell Line, Tumor; Child; Dasatinib; Humans; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mammals; Mechanistic Target of Rapamycin Complex 1; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptors, Antigen, T-Cell; Recurrence; Signal Transduction; T-Lymphocytes; Tyrosine; Zebrafish

2022